317 related articles for article (PubMed ID: 25079966)
1. Tunable T1 and T2 contrast abilities of manganese-engineered iron oxide nanoparticles through size control.
Huang G; Li H; Chen J; Zhao Z; Yang L; Chi X; Chen Z; Wang X; Gao J
Nanoscale; 2014 Sep; 6(17):10404-12. PubMed ID: 25079966
[TBL] [Abstract][Full Text] [Related]
2. Highly monodisperse low-magnetization magnetite nanocubes as simultaneous T(1)-T(2) MRI contrast agents.
Sharma VK; Alipour A; Soran-Erdem Z; Aykut ZG; Demir HV
Nanoscale; 2015 Jun; 7(23):10519-26. PubMed ID: 26010145
[TBL] [Abstract][Full Text] [Related]
3. Europium-engineered iron oxide nanocubes with high T1 and T2 contrast abilities for MRI in living subjects.
Yang L; Zhou Z; Liu H; Wu C; Zhang H; Huang G; Ai H; Gao J
Nanoscale; 2015 Apr; 7(15):6843-50. PubMed ID: 25806860
[TBL] [Abstract][Full Text] [Related]
4. Manganese doped iron oxide theranostic nanoparticles for combined T1 magnetic resonance imaging and photothermal therapy.
Zhang M; Cao Y; Wang L; Ma Y; Tu X; Zhang Z
ACS Appl Mater Interfaces; 2015 Mar; 7(8):4650-8. PubMed ID: 25672225
[TBL] [Abstract][Full Text] [Related]
5. Contrast agents for MRI.
Shokrollahi H
Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4485-97. PubMed ID: 24094150
[TBL] [Abstract][Full Text] [Related]
6. Fabrication of contrast agents for magnetic resonance imaging from polymer-brush-afforded iron oxide magnetic nanoparticles prepared by surface-initiated living radical polymerization.
Ohno K; Mori C; Akashi T; Yoshida S; Tago Y; Tsujii Y; Tabata Y
Biomacromolecules; 2013 Oct; 14(10):3453-62. PubMed ID: 23957585
[TBL] [Abstract][Full Text] [Related]
7. Engineering manganese ferrite shell on iron oxide nanoparticles for enhanced T
Li M; Bao J; Zeng J; Huo L; Shan X; Cheng X; Qiu D; Miao W; Zhu X; Huang G; Ni K; Zhao Z
J Colloid Interface Sci; 2022 Nov; 626():364-373. PubMed ID: 35797871
[TBL] [Abstract][Full Text] [Related]
8. In vivo identification of sentinel lymph nodes using MRI and size-controlled and monodispersed magnetite nanoparticles.
Iida S; Imai K; Matsuda S; Itano O; Hatakeyama M; Sakamoto S; Kokuryo D; Okabayashi K; Endo T; Ishii Y; Hasegawa H; Aoki I; Handa H; Kitagawa Y
J Magn Reson Imaging; 2013 Dec; 38(6):1346-55. PubMed ID: 23554026
[TBL] [Abstract][Full Text] [Related]
9. Synthesis Of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles With High Relaxivity For T
Xiao S; Yu X; Zhang L; Zhang Y; Fan W; Sun T; Zhou C; Liu Y; Liu Y; Gong M; Zhang D
Int J Nanomedicine; 2019; 14():8499-8507. PubMed ID: 31695377
[TBL] [Abstract][Full Text] [Related]
10. High-resolution cellular MRI: gadolinium and iron oxide nanoparticles for in-depth dual-cell imaging of engineered tissue constructs.
Di Corato R; Gazeau F; Le Visage C; Fayol D; Levitz P; Lux F; Letourneur D; Luciani N; Tillement O; Wilhelm C
ACS Nano; 2013 Sep; 7(9):7500-12. PubMed ID: 23924160
[TBL] [Abstract][Full Text] [Related]
11. Long-circulating PEGylated manganese ferrite nanoparticles for MRI-based molecular imaging.
Pernia Leal M; Rivera-Fernández S; Franco JM; Pozo D; de la Fuente JM; García-Martín ML
Nanoscale; 2015 Feb; 7(5):2050-9. PubMed ID: 25554363
[TBL] [Abstract][Full Text] [Related]
12. A new class of cubic SPIONs as a dual-mode T1 and T2 contrast agent for MRI.
Alipour A; Soran-Erdem Z; Utkur M; Sharma VK; Algin O; Saritas EU; Demir HV
Magn Reson Imaging; 2018 Jun; 49():16-24. PubMed ID: 28958878
[TBL] [Abstract][Full Text] [Related]
13. Mn(2+)-doped silica nanoparticles for hepatocyte-targeted detection of liver cancer in T1-weighted MRI.
Kim SM; Im GH; Lee DG; Lee JH; Lee WJ; Lee IS
Biomaterials; 2013 Nov; 34(35):8941-8. PubMed ID: 23973173
[TBL] [Abstract][Full Text] [Related]
14. Bioinspired synthesis and characterization of gadolinium-labeled magnetite nanoparticles for dual contrast t1- and T2-weighted magnetic resonance imaging.
Bae KH; Kim YB; Lee Y; Hwang J; Park H; Park TG
Bioconjug Chem; 2010 Mar; 21(3):505-12. PubMed ID: 20166678
[TBL] [Abstract][Full Text] [Related]
15. Redoxable heteronanocrystals functioning magnetic relaxation switch for activatable T1 and T2 dual-mode magnetic resonance imaging.
Kim MH; Son HY; Kim GY; Park K; Huh YM; Haam S
Biomaterials; 2016 Sep; 101():121-30. PubMed ID: 27281684
[TBL] [Abstract][Full Text] [Related]
16. Octapod iron oxide nanoparticles as high-performance T₂ contrast agents for magnetic resonance imaging.
Zhao Z; Zhou Z; Bao J; Wang Z; Hu J; Chi X; Ni K; Wang R; Chen X; Chen Z; Gao J
Nat Commun; 2013; 4():2266. PubMed ID: 23903002
[TBL] [Abstract][Full Text] [Related]
17. Activatable molecular MRI nanoprobe for tumor cell imaging based on gadolinium oxide and iron oxide nanoparticle.
Li J; Wang S; Wu C; Dai Y; Hou P; Han C; Xu K
Biosens Bioelectron; 2016 Dec; 86():1047-1053. PubMed ID: 27501342
[TBL] [Abstract][Full Text] [Related]
18. T1-T2 dual-modal MRI of brain gliomas using PEGylated Gd-doped iron oxide nanoparticles.
Xiao N; Gu W; Wang H; Deng Y; Shi X; Ye L
J Colloid Interface Sci; 2014 Mar; 417():159-65. PubMed ID: 24407672
[TBL] [Abstract][Full Text] [Related]
19. Paramagnetic and Superparamagnetic Inorganic Nanoparticles for T1-Weighted Magnetic Resonance Imaging.
Zeng L; Wu D; Zou R; Chen T; Zhang J; Wu A
Curr Med Chem; 2018; 25(25):2970-2986. PubMed ID: 28292235
[TBL] [Abstract][Full Text] [Related]
20. Labeling of cancer cells with magnetic nanoparticles for magnetic resonance imaging.
Weis C; Blank F; West A; Black G; Woodward RC; Carroll MR; Mainka A; Kartmann R; Brandl A; Bruns H; Hallam E; Shaw J; Murphy J; Teoh WY; Aifantis KE; Amal R; House M; Pierre TS; Fabry B
Magn Reson Med; 2014 May; 71(5):1896-905. PubMed ID: 23813415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
